Artesunate/mefloquine
From Wikipedia, the free encyclopedia
| Combination of | |
|---|---|
| Artesunate | Artemisinin |
| Mefloquine | Antimalarial |
| Clinical data | |
| ATC code | |
| Identifiers | |
| CAS Number | |
| CompTox Dashboard (EPA) | |
Artesunate/mefloquine is a medication used to treat malaria.[1] It is a fixed dose combination of artesunate and mefloquine.[1] Specifically it is recommended to treat uncomplicated falciparum malaria.[2] It is taken by mouth.[1]
Side effects are similar to the medications being used separately.[2] Use is recommended as it decreases the possibility of either medications being used alone.[2] Dose forms appropriate for children are also available.[2]
Artesunate/mefloquine came into commercial use in 2008.[3] It is on the World Health Organization's List of Essential Medicines.[1] It is approved for medical use in Brazil, India, and Malaysia.[2] It is not commercially available in the United States.[4]
